Yükleniyor... / Loading...
This study examines whether a multidisciplinary medication review with follow-up improves treatment control in primary care patients taking coumarin-type blood thinners (acenocoumarol). It was open to patients whose time in the therapeutic range was below 70% over the previous 6 months. It was conducted as a study with no assigned phase and has been completed.
The summary above is a plain-language rendering of the official record. The original English title is shown for reference.
Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.
Inclusion Criteria: * Submit a TTR less than 70% in the last 6 months. Exclusion Criteria: * Not sign the informed consent. * Present cognitive difficulties for the project.